Year 2 Project
Melissa Brouwers, University of Ottawa, Co-Lead of Pillar 9: Knowledge, Implementation, and Training Team (KITT) and, Project Co-Lead
Jeremy Grimshaw, Ottawa Hospital Research Institute, Co-Lead of Pillar 9: Knowledge, Implementation, and Training Team (KITT) and, Project Co-Lead
Paul Bonnar, Dalhousie University, Pillar 9 Member
Janet Curran, Dalhousie University, Pillar 9 Member
Joyce Dogba, Université Laval, Pillar 9 Member
Alfonso Iorio, McMaster University, Pillar 9 Member
John Lavis, McMaster University, Pillar 9 Deputy
Lori-Ann Linkins, McMaster University, Pillar 9 Member
Julian Little, University of Ottawa, Pillar 9 Member
Andrew Morris, University of Toronto, Pillar 9 Deputy
Menaka Pai, McMaster University, Pillar 9 Member
Justin Presseau, Ottawa Hospital Research Institute, Pillar 9 Deputy
Based on progress made during our first year of research, and in keeping with our guiding principles of being responsive, participatory, collaborative, and evidence-informed, we have identified three priority areas on which to focus during Year 2:
- Support the development of high-quality guidelines that can be tailored to specific jurisdictions across Canada, with particular emphasis on therapeutic and behavioral interventions for clinical practice on COVID-19.
- Employ behavioural science methods to identify key factors associated with both acceptance and adherence to public health measures and uptake of vaccination, and to use this understanding to develop public-facing materials.
- Build the expertise and skills required to take on specific contemporary public health challenges related to pandemics with online learning modules that address such topics as vaccine surveillance, contact tracing, and risk communication.
Our ability to create and implement resources in support of basic scientists, clinicians, public health officials, and policymakers will play a key role in ending the current pandemic and establishing a nimbler system in response to future pandemics and other public health challenges.
$625,000 cash contribution